Copyright © 2004 by the European Society of Cardiology.
Clinical research
Incidence, diagnostic yield and safety of the implantable loop-recorder to detect the mechanism of syncope in patients with and without structural heart disease
a Arrhythmologic Centre, Department of Cardiology, Ospedali del Tigullio, Via don Bobbio 25, 16033 Lavagna, Italy
b Interventional Cardiology Unit, Department of Cardiology, Azienda Ospedaliera Santa Maria Nuova, Reggio nell'Emilia, Italy
* Corresponding author. Fax: +39-185-306506
E-mail address: aritmo{at}asl4.liguria.it
Received 22 December 2003; revised 5 April 2004; accepted 13 May 2004
Abstract
Aim To evaluate the incidence, diagnostic yield and safety of implantable loop recorders (ILRs) in patients with or without structural heart disease (SHD).
Methods and results Two-hospitals, observational, prospective study in consecutive patients with unexplained syncope who underwent an ILR implantation. Between November 1997 and December 2002, a total of 2052 patients with syncope were evaluated (referral population of 590000 inhabitants). The diagnosis remained unexplained in 371 (18%). Of these, 103 patients (5% of total, 28% of unexplained syncope) received an ILR. SHD was present in 38 (37%), and absent in 65 (63%). During a median follow-up of 13 months, syncope was recorded in 52 patients. While patients with and without SHD had similar incidence of syncope recurrence, its mechanism was different. Patients with SHD more frequently had paroxysmal AV block and tachyarrhythmias and patients without SHD more frequently had sinus bradycardia/sinus arrest or no arrhythmia. More patients with SHD finally received an ILR-guided therapy. Sudden death occurred in one patient with SHD. Five syncope-related injuries were noted in 3 patients.
Conclusion The mechanism of syncope is different in patients with and without SHD; diagnostic yield and safety are similar in both groups. About 28% of patients with unexplained syncope have an indication to ILR implantation. The need for ILR implantation in the general population is 34 implants/million inhabitants/year.
Key Words: Syncope • Implantable loop-recorder • Arrhythmia • Pacemaker
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Developed in collaboration with, European Heart Rhythm Association (EHRA), Heart Failure Association (HFA), and Heart Rhythm Society (HRS), Endorsed by the following societies, European Society of Emergency Medicine (EuSEM), European Federation of Internal Medicine (EFIM), European Union Geriatric Medicine Society (EUGMS), American Geriatrics Society (AGS), European Neurological Society (ENS), et al. Guidelines for the diagnosis and management of syncope (version 2009): The Task Force for the Diagnosis and Management of Syncope of the European Society of Cardiology (ESC) Eur. Heart J., November 1, 2009; 30(21): 2631 - 2671. [Full Text] [PDF]
|
|
|
|
 |
|
 Task Force members, M. Brignole, P. Vardas, E. Hoffman, H. Huikuri, A. Moya, R. Ricci, N. Sulke, W. Wieling, EHRA Scientific Documents Committee, et al. Indications for the use of diagnostic implantable and external ECG loop recorders Europace, May 1, 2009; 11(5): 671 - 687. [Full Text] [PDF]
|
|
|
|
 |
|
 M. Brignole, J.-J. Blanc, R. Sutton, and A. Moya CHAPTER 26 Syncope ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T Pezawas, G Stix, J Kastner, B Schneider, M Wolzt, and H Schmidinger Implantable loop recorder in unexplained syncope: classification, mechanism, transient loss of consciousness and role of major depressive disorder in patients with and without structural heart disease Heart, April 1, 2008; 94(4): e17 - e17. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Brignole, F. Giada, A. Raviele, and J. J. Blanc Pacing for syncope: what role? which perspective? Eur. Heart J. Suppl., December 1, 2007; 9(suppl_I): I37 - I43. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
The Steering Committee of the ISSUE 3 Study International study on syncope of uncertain aetiology 3 (ISSUE 3): pacemaker therapy for patients with asystolic neurally-mediated syncope: rationale and study design Europace, January 1, 2007; 9(1): 25 - 30. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Lawo, M. Borggrefe, C. Butter, G. Hindricks, H. Schmidinger, Y. Mika, D. Burkhoff, C. Pappone, and H. N. Sabbah Electrical Signals Applied During the Absolute Refractory Period: An Investigational Treatment for Advanced Heart Failure in Patients With Normal QRS Duration J. Am. Coll. Cardiol., December 20, 2005; 46(12): 2229 - 2236. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Burkhoff and S. A. Ben-Haim Nonexcitatory electrical signals for enhancing ventricular contractility: rationale and initial investigations of an experimental treatment for heart failure Am J Physiol Heart Circ Physiol, June 1, 2005; 288(6): H2550 - H2556. [Full Text] [PDF]
|
|
|
|
|
|
M. Brignole, A. Moya, C. Menozzi, R. Garcia-Civera, and R. Sutton Proposed electrocardiographic classification of spontaneous syncope documented by an implantable loop recorder Europace, January 1, 2005; 7(1): 14 - 18. [Abstract] [Full Text] [PDF]
|
|